U.S. federal regulations for emergency research: A practical guide and commentary

Academic Emergency Medicine

Volumn 15, Issue 1, 2008, Pages 88-97

  McRae, Andrew ^a,b   Weijer, Charles ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Bioethics; Community consultation; Emergency research; Federal regulations; Research ethics

Indexed keywords

ANALGESIC AGENT; SEDATIVE AGENT;

ANALGESIA; BELMONT PRINCIPLE; CHILD HEALTH; CHILDHOOD DISEASE; COMMON RULE; COMPONENT ANALYSIS; CONCEPT ANALYSIS; DOCUMENTATION; EMERGENCY HEALTH SERVICE; FRACTURE; HEALTH CARE POLICY; HUMAN; INFORMED CONSENT; INSTITUTIONAL ETHICS; LAW; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICAL RESEARCH; MINIMAL RISK CONCEPT; NOMENCLATURE; PAIN; PATIENT DECISION MAKING; PRIORITY JOURNAL; PRIVACY; RESUSCITATION; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SEDATION; UNITED STATES; ADULT; CHILD; EMERGENCY MEDICINE; FEMALE; FINANCIAL MANAGEMENT; GOVERNMENT; LEGAL ASPECT; PREGNANCY; RESEARCH; RESEARCH SUBJECT;

ADULT; CHILD; EMERGENCY MEDICINE; FEDERAL GOVERNMENT; FEMALE; HUMANS; INFORMED CONSENT; PREGNANCY; RESEARCH; RESEARCH SUBJECTS; RESEARCH SUPPORT AS TOPIC; UNITED STATES;

EID: 44449096318     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1553-2712.2007.00001.x     Document Type: Review

References (44)

1. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, DC: Government Printing Office, 1979.
2. Department of Health and Human Services. Rules and regulations: Protection of human subjects. Title 45, code of federal regulations, part 46. Fed Regist. 1991; 56:28003.
3. Department of Health and Human Services. Additional protections for children involved as subjects in research. Title 45, code of federal regulations, part 46, subparts 401-409. Fed Regist. 1991; 56:28003.
4. Department of Health and Human Services. Additional protections for pregnant women, human fetuses, and neonates involved in research. Title 45 code of federal regulations, part 46, subparts 201-207. Fed Regist. 1991; 56:28003.
5. Department of Health and Human Services. Additional protections pertaining to biomedical and behavioral research involving prisoners as subjects. Title 45, code of federal regulations, part 46, subparts 301-306. Fed Regist. 1991; 56:28003.
6. Food and Drug Administration. Title 21 CFR 50.24. Exception from informed consent requirements for emergency research. Fed Regist. 1996; 61:51528.
7. Department of Health and Human Services Office for Civil Rights. HIPAA: Medical Privacy-Standards to Protect Privacy of Personal Health Information. Available at: http://www.hhs.gov/ocr/hipaa/. Accessed Jun 23, 2007.
8. Shahan JB, Kelen GD. Research ethics. Emerg Med Clin N Am. 2006; 24:657-69.
9. Department of Health and Human Services. Protection of human subjects: categories or research that may be reviewed by the institutional review board (IRB) through an expedited review procedure. Fed Regist. 1998; 63:60364-7.
10. Marco CA, Plewa MC, Buderer N, Black C, Roberts A. Comparison of oxycodone and hydrocodone for the treatment of acute pain associated with fractures: a double-blind, randomized, controlled trial. Acad Emerg Med. 2005; 12:282-8.
11. Taylor DM, O'Brien D, Ritchie P, Pasco J, Cameron PA. Propofol versus Midazolam/Fentanyl for reduction of anterior shoulder dislocation. Acad Emerg Med. 2005; 12:13-9.
12. Weijer C, Miller PB. When are research risks reasonable in relation to anticipated benefits. In: Amdur RJ, Bankert EA (eds). Institutional Review Board Member Handbook. Sudbury, MA: Jones and Bartlett, 2006.
13. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987; 317:141-5.
14. Stork CM, Brown KM, Reilly TH, Secreti L, Brown LH. Emergency department treatment of viral gastritis using ondansetron or dexamethasone in children. Acad Emerg Med. 2006; 13:1027-33.
15. Qureshi F, Zaritsky F, Welch C, Meadows T, Burke BL. Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma. Ann Emerg Med. 2005; 46:29-36.
16. Berger JE, Committee on Medial Liability. Consent by proxy for nonurgent pediatric care. Pediatrics. 2003; 112:1186-95.
17. National Cancer Institute. Children's Assent to Clinical Trial Participation. Available at: http://www.cancer.gov/clinicaltrials/understanding/ childrensassent0101. Accessed Jun 23, 2007.
18. Weijer C, Miller PB. When are research risks reasonable in relation to anticipated benefits? Nat Med. 2004; 10:570-3.
19. National Bioethics Advisory Commission. Ethical and Policy Issues in Research Involving Human Participants. Chapter 3: Policy, Regulation, and Guidance: Selected Ethical Issues for Protecting Research Participants. Available at: http://www.bioethics.gov/reports/past_commissions/nbac_human_part. pdf. Accessed Jun 23, 2007.
20. Melniker LA, Liebner E, Mckenney M, Lopez P, Briggs WM, Mancuso CA. Randomized, controlled trial of point-of-care limited ultrasonography for trauma in the emergency department: the first sonography outcomes assessment program trial. Ann Emerg Med. 2006; 48:227-35.
21. Karlawish JH. Research involving cognitively impaired adults. N Engl J Med. 2003; 348:1389-92.
22. Weijer C. Is clinical research and ethics a zero-sum game? Crit Care Med. 2005; 33:912-3.
23. Department of Health, Education, and Welfare. Protection of human subjects: proposed regulations on research involving those institutionalized as mentally disabled. Fed Regist. 1978; 43:53950-6.
24. Biros MH. Research without consent: current status, 2003. Ann Emerg Med. 2003; 42:550-64.
25. Sloan EP, Koenigsberg M, Gens D, et al. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA. 1999; 282:1857-64.
26. Kudenchuk PJ, Cobb LA, Copass MK, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med. 1999; 341:871-8.
27. Ellis G. Informed consent: legally effective and prospectively obtained: office of protection from research risks. OPRR Rep. 1993; 93:3.
28. Biros MH, Runge JW, Lewis RJ, Doherty C. Emergency medicine and the development of the food and drug administration's final rule on informed consent and waiver of informed consent in emergency research circumstances. Acad Emerg Med. 1998; 5:359-68.
29. Biros M. Struggling with the rule: the exception from informed consent for resuscitation research. Acad Emerg Med. 2007; 14:344-5.
30. Watters D, Sayre MR, Silbergleit R. Research conditions that qualify for emergency exception from informed consent. Acad Emerg Med. 2005; 12:1040-4.
31. Food and Drug Administration, ed. Guidance for Institutional Review Boards and Clinical Investigators 1998 Update. Exception from Informed Consent for Studies Conducted in Emergency Settings: Regulatory Language and Excerpts from Preamble. Washington, D.C.: U.S. Government Printing Office, 1998.
32. Ernst AA, Fish S. Exception from informed consent: viewpoint of institutional review boards-balancing risks to subjects, community consultation, and future directions. Acad Emerg Med. 2005; 12:1050-5.
33. Mosesso VN, Cone DC. Using the exception from informed consent regulations in research. Acad Emerg Med. 2005; 12:1031-9.
34. Baren JM, Biros M. The research on community consultation: an annotated bibliography. Acad Emerg Med. 2007; 14:346-52.
35. McRae AD, Weijer C. Waiver of consent for emergency research. Ann Emerg Med. 2004; 44:278-9.
36. Silverman HJ, Luce JM, Schwartz J. Protecting subjects with decisional impairment in research: the need for a multifaceted approach. Am J Respir Crit Care Med. 2004; 169:10-4.
37. McRae AD, Weijer C. Lessons from everyday lives: a moral justification for acute care research. Crit Care Med. 2002; 30:1146-51.
38. McRae AD, Ackroyd-Stolarz S, Weijer C. Risk in emergency research using a waiver of consent: implications of a structured approach for IRB review. Acad Emerg Med. 2005; 12:1104-12.
39. Hock MO, Ooi SB, Saw SM, Lim SH. A randomized, controlled trial examining the hair apposition technique with tissue glue to standard suturing in scalp lacerations (HAT study). Ann Emerg Med. 2002; 40:19-26.
40. Perelman VS, Francis GJ, Rutledge T, et al. Sterile versus nonsterile gloves for repair of uncomplicated lacerations in the emergency department. Ann Emerg Med. 2004; 43:362-70.
41. Sloan EP, Koenigsberg M, Houghton J, et al. The informed consent process and the use of the exception to informed consent in the clinical trial of diaspirin cross-linked hemoglobin (DCLHb) in severe traumatic hemorrhagic shock. DCLHb traumatic hemorrhagic shock study group. Acad Emerg Med. 1999; 6:1203-9.
42. Sloan EP, Nagy K, Barrett J. A proposed consent process in studies that use an exception to informed consent. Acad Emerg Med. 1999; 6:1283-91.
43. Martel M, Sterzinger A, Miner J, Clinton J, Biros M. Management of acute undifferentiated agitation in the emergency department: a randomized, controlled trial of droperidol, ziprasidone, and midazolam. Acad Emerg Med. 2005; 12:1167-72.
44. Santora TA, Cowell V, Trooszkin SZ. Working through the public disclosure process mandated by use of 21 CFR 50.24 (exception to informed consent): guidelines for success. J Trauma. 1998; 45:907-13.